Onconova Therapeutics (ONTX) Financials

$15.63

$7.70 (97.10%)

As on 09-Sep-2026 14:45EDT

Market cap

$21 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	0.23	0.23	0.23	0.23	0.23	2.18
Cost of Revenue	0.01	-225,999.77	0.01	0.01	--	--
Gross Profit	0.16	226,000.00	0.23	0.21	0.23	2.18
Operating Expenses	18.85	20.52	19.85	16.72	25.22	23.88
Operating Profit (EBIT)	-18.62	-20.30	-19.63	-16.50	-24.99	-21.70
Other Income	--	--	--	--	-0.16	0.21
Profit before Tax	-17.36	-18.95	-18.96	-16.16	-25.15	-21.49
Provision for Tax	0.00	--	-0.66	-0.34	0.00	0.01
Profit after Tax (Net Income)	-17.36	-18.95	-18.30	-15.83	-25.16	-21.50
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-4.25	--	-18.96	-16.16	-25.16	-21.50

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	10.67	10.67	28.31	46.12	6.18	11.57
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	2.79	2.79	3.02	3.24	3.79	3.81
Current Liabilities	9.22	9.22	8.05	6.12	10.02	8.29
Total Liabilities	31.90	22.68	39.37	55.48	19.99	23.67

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	0.02	0.02	0.03	0.05	0.20	0.20
Current Assets	22.66	22.66	39.35	55.43	19.78	23.47
Total Assets	45.34	22.68	39.37	55.48	19.99	23.67
Total Debt*	--	--	--	--	--	--
Net Current Assets	--	13.44	31.30	49.32	9.76	15.18

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-17.93	-16.29	-19.49	-23.08	-20.83
Cash Flow from Investing Activities	--	--	--	--	-0.02	-0.06
Cash from Financing Activities	--	-17,935,982.06	-0.04	55.56	19.36	26.65
Net Cash Inflow / Outflow	--	--	--	--	-3.73	5.76

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-97.22	-49.18	-60.53	-283.48	-253.56
ROE (%)	-137.81	-97.22	-49.18	-60.53	-283.48	-253.56
ROA (%)	-38.73	-61.07	-38.59	-41.95	-115.24	-103.39
EBIT Margin (%)	-6,267.70	-8,981.42	-8,684.51	-7,299.12	-10,819.48	-994.00
Net Margin (%)	-7,680.09	-8,384.07	-8,097.79	-7,003.54	-35,432.39	-900.08
Cash Profit Margin (%)	-0.59	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	--	--	--	-0.02	-0.89	0.78
EBIT Growth (%)	34.54	-3.42	-18.98	34.00	-15.18	12.97
Net Profit Growth (%)	10.97	-3.54	-15.62	37.08	-16.99	-4.52
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	--	--	--	--	--
Price / Book Value	1.86	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.05	1.03	1.98	3.27	0.77	1.04
Close Price ($)	1.01	0.75	0.65	2.55	6.99	5.75
High Price ($)	1.45	1.49	2.84	28.95	23.40	72.39
Low Price ($)	0.55	0.55	0.62	2.45	2.85	1.54
Market Cap ($ Cr)	20.90	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	316,247.81	--	--	--	--
Current Ratio	2.46	2.46	4.89	9.06	1.97	2.83
Quick Ratio	2.30	2.30	4.88	9.06	1.97	2.83
Interest Coverage	--	--	-1,401.93	-49.24	-70.40	-76.67

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	7.96	7.96	12.83	12.39	16.02	4.49
Asset Turnover	0.01	0.01	0.00	0.01	0.01	0.10
Receivable days	--	37.98	46.06	52.52	106.73	11.13
Inventory Days	--	0.00	1,643.63	1,552.31	--	--
Payable days	--	-0.01	86,316.40	99,008.84	--	--
Cash Conversion Cycle	--	37.99	-84,626.72	-97,404.00	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.